We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,423 results
  1. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival

    The epigenetic changes associated with melanoma progression to advanced and metastatic stages are still poorly understood. To shed light on the CpG...

    Flávia E. Rius, Debora D. Papaiz, ... Miriam G. Jasiulionis in Clinical Epigenetics
    Article Open access 23 May 2022
  2. Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

    Background

    The mitogen-activated protein kinase (MAPK) signaling pathway is frequently hyperactivated in malignant melanoma and its inhibition has...

    Corinna Kosnopfel, Simone Wendlinger, ... Birgit Schittek in Journal of Experimental & Clinical Cancer Research
    Article Open access 19 July 2023
  3. Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice

    Recent pan-cancer genomic analyses have identified numerous oncogenic driver mutations that occur in a cell-type and tissue-specific distribution....

    Miriam Mengoni, Andreas Dominik Braun, ... Evelyn Gaffal in Cancer Gene Therapy
    Article Open access 15 February 2024
  4. BLOC1S5 pathogenic variants cause a new type of Hermansky–Pudlak syndrome

    Purpose

    Hermansky–Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, excessive bleeding, and often additional symptoms. Variants in...

    Perrine Pennamen, Linh Le, ... Benoit Arveiler in Genetics in Medicine
    Article 22 June 2020
  5. Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent conditions

    Background

    Although rare, uveal melanoma (UM) is a life-threatening malignancy. Understanding its biology is necessary to improve disease outcome....

    Alicia A. Goyeneche, Jade M. E. Lasiste, ... Miguel N. Burnier Jr. in Cancer Cell International
    Article Open access 23 May 2024
  6. Genomic and metabolic analyses reveal antagonistic lanthipeptides in archaea

    Background

    Microbes produce diverse secondary metabolites (SMs) such as signaling molecules and antimicrobials that mediate microbe-microbe...

    Haoyu Liang, Zhi-Man Song, ... Yong-**n Li in Microbiome
    Article Open access 14 April 2023
  7. Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers

    Cutaneous melanoma is one of the most aggressive forms of skin cancer, with the development of advanced stage disease resulting in a high rate of...

    Giang T. Lam, Sarita Prabhakaran, ... Jessica M. Logan in Molecular Diagnosis & Therapy
    Article 07 December 2022
  8. CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth

    Background

    Though the CXCR2 chemokine receptor is known to play a key role in cancer growth and response to therapy, a direct link between expression...

    J. Yang, K. Bergdorf, ... A. Richmond in Molecular Cancer
    Article Open access 03 June 2023
  9. Molecular mimicry and cancer vaccine development

    Background

    The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which...

    Maria Tagliamonte, Beatrice Cavalluzzo, ... Luigi Buonaguro in Molecular Cancer
    Article Open access 26 April 2023
  10. Local recurrence of melanocytoma of the cervical spine

    Eleanor M. Moncur, Selma Al-Ahmad, ... David Choi in Acta Neurologica Belgica
    Article Open access 06 February 2024
  11. CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response

    Background

    Immune checkpoint blockade (ICB) has significantly prolonged survival of non-small cell lung cancer (NSCLC) patients, although most...

    Belinda Palermo, Ornella Franzese, ... Paola Nisticò in Journal of Experimental & Clinical Cancer Research
    Article Open access 28 October 2023
  12. In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery

    In vitro-transcribed mRNAs (IVT-mRNAs) are easily and rapidly designed in vitro synthesized RNA molecules. After their intracellular delivery through...
    A. N. Miliotou, I. S. Pappas, ... L. C. Papadopoulou in Messenger RNA Therapeutics
    Chapter 2022
  13. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade

    Background

    Tumor regression following immune checkpoint blockade (ICB) is often associated with immune-related adverse events (irAEs), marked by...

    Shuming Chen, Tracee L. McMiller, ... Suzanne L. Topalian in Journal of Translational Medicine
    Article Open access 05 March 2024
  14. Simultaneous endocrine expression and loss of melanoma markers in malignant melanoma metastases, a retrospective analysis

    Malignant melanoma metastases are chameleons of histopathology. In 4 primary malignant melanomas and 20 melanoma metastases expression of S-100,...

    Claus Steppert, Jens Krugmann, William Sterlacci in Pathology & Oncology Research
    Article 25 October 2019
  15. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis

    Background

    We have previously developed a murine cellular system that models the transformation from melanocytes to metastatic melanoma cells. This...

    Hátylas Azevedo, Guilherme Cavalcante Pessoa, ... Miriam Galvonas Jasiulionis in Clinical Epigenetics
    Article Open access 24 August 2020
  16. Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma

    Background

    Systemic therapy for metastatic clear cell sarcoma (CCS) bearing EWSR1-CREB1/ATF1 fusions remains an unmet clinical need in children,...

    Samuel V. Rasmussen, Agnieszka Wozniak, ... Charles Keller in British Journal of Cancer
    Article 23 March 2023
  17. Simultaneous diagnosis of liver PEComa in a family with known Li–Fraumeni syndrome: a case report

    Background

    Li–Fraumeni syndrome (LFS) is an autosomal dominant hereditary disease. It is associated with the loss of function of the p53 protein and...

    María del Mar Galera López, Iván Márquez Rodas, ... Rosa Álvarez Álvarez in Clinical Sarcoma Research
    Article Open access 24 November 2020
  18. Two New Species of Annulotrema (Monogenea: Dactylogyridae) Gill Parasites of Brycinus macrolepidotus Valenciennes, 1849 from Nyong River, Cameroon

    Purpose

    Research on gill monogeneans of Characiform has made it possible to find two new species belonging to the genus Annulotrema . The purpose of...

    Ivan Ndongo, John Francis Akoumba, ... Abraham Fomena in Acta Parasitologica
    Article 18 January 2023
Did you find what you were looking for? Share feedback.